{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:27:46Z","timestamp":1740115666131,"version":"3.37.3"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7,15]]},"DOI":"10.1097\/tp.0b013e3181de9193","type":"journal-article","created":{"date-parts":[[2010,5,5]],"date-time":"2010-05-05T08:50:50Z","timestamp":1273049450000},"page":"23-30","source":"Crossref","is-referenced-by-count":11,"title":["Enteric-Coated Mycophenolate Sodium Versus Mycophenolate Mofetil Maintenance Immunosuppression: Outcomes Analysis of the United Network for Organ Sharing\/Organ Procurement and Transplantation Network Database"],"prefix":"10.1097","volume":"90","author":[{"given":"William","family":"Irish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Arcona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan J.","family":"Gifford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Mark","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation.","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection.","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients.","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1600-6143.2003.00321.x","article-title":"Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study.","volume":"4","author":"Budde","year":"2004","journal-title":"Am J Transplant"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1399-0012.2004.00203.x","article-title":"Mycophenolates in transplantation.","volume":"18","author":"Sollinger","year":"2004","journal-title":"Clin Transplant"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-2277.2004.tb00394.x","article-title":"Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil.","volume":"17","author":"Hardinger","year":"2004","journal-title":"Transpl Int"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","article-title":"Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation.","volume":"14","author":"Knoll","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","article-title":"The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.","volume":"17","author":"Pelletier","year":"2003","journal-title":"Clin Transplant"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","article-title":"Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients.","volume":"19","author":"Tierce","year":"2005","journal-title":"Clin Transplant"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/00007890-200211270-00005","article-title":"Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: A paired donor kidney analysis.","volume":"74","author":"Meier-Kriesche","year":"2002","journal-title":"Transplantation"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation of incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"R15-5-20210129","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/sim.1903","article-title":"Stratification and weighting via the propensity score in estimation of causal treatment effects: A comparative study.","volume":"23","author":"Lunceford","year":"2004","journal-title":"Stat Med"},{"article-title":"Applied logistic regression.","year":"1989","author":"Hosmer","key":"R17-5-20210129"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2530647","article-title":"The bias due to incomplete matching.","volume":"41","author":"Rosenbaum","year":"1985","journal-title":"Biometrics"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables (with discussion).","volume":"34","author":"Cox","year":"1972","journal-title":"J Royal Stat Soc B"},{"article-title":"Applied survival analysis.","year":"1999","author":"Hosmer","key":"R20-5-20210129"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/TP.0b013e3181b0e65e","article-title":"Comparing outcomes associated with dose manipulations of enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients.","volume":"88","author":"Cooper","year":"2009","journal-title":"Transplantation"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/TP.0b013e31817d4df5","article-title":"Expanding the evidence base in transplantation: The complementary roles of randomized controlled trials and outcomes research.","volume":"86","author":"Takemoto","year":"2008","journal-title":"Transplantation"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MLR.0b013e3180326121","article-title":"Linking the US transplant registry to administrative claims data: Expanding the potential of transplant research.","volume":"45","author":"Gilmore","year":"2007","journal-title":"Med Care"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1681\/ASN.2006030258","article-title":"Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey.","volume":"17","author":"Stirnemann","year":"2006","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3181de9193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T15:09:04Z","timestamp":1740064144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201007150-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,15]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181de9193","relation":{},"ISSN":["0041-1337"],"issn-type":[{"type":"print","value":"0041-1337"}],"subject":[],"published":{"date-parts":[[2010,7,15]]}}}